Universe Pharmaceuticals (UPC) Cash & Equivalents (2020 - 2026)
Universe Pharmaceuticals (UPC) reported Cash & Equivalents of $27.56 million for the quarter ended Mar 31, 2026, down 41.7% from $47.27 million a year earlier.
Powered by 
Analysis
Universe Pharmaceuticals (UPC) Cash & Equivalents (2020 - 2026) Analysis & Trends
As of Sep 30, 2025, Universe Pharmaceuticals posted Cash & Equivalents of $33.59 billion.
- Cash & Equivalents has a five-year compound annual growth rate of 406.7% (years ended Sep 2020 to Sep 2025).
- By year, Cash & Equivalents came in at $29.5 million in the year ended Sep 30, 2024 (-99.4%), $5.29 billion in the year ended Sep 30, 2023 (-7.5%), $5.71 billion in the year ended Sep 30, 2022 and $8.08 million in the year ended Sep 30, 2021 (-19.7%).
- The figure for the quarter ended Mar 31, 2026 ranks as the lowest quarterly Cash & Equivalents since the quarter ended Mar 31, 2024.
- The high point for year-over-year Cash & Equivalents in five years was the quarter ended Mar 31, 2025 (growth of 433.5%); the low point was the quarter ended Sep 30, 2024 (a decline of 99.4%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Universe Pharmaceuticals | 1.96 Mn | -1,525.28 Bn | - | 27.56 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 27.56 Mn |
| Sep 30, 2025 | 33.59 Bn |
| Mar 31, 2025 | 47.27 Mn |
| Sep 30, 2024 | 29.50 Mn |
| Mar 31, 2024 | 8.86 Mn |
| Sep 30, 2023 | 5.29 Bn |
| Mar 31, 2023 | 12.95 Mn |
| Sep 30, 2022 | 5.71 Bn |
| Mar 31, 2022 | 14.24 Mn |
| Sep 30, 2021 | 8.08 Mn |
| Mar 31, 2021 | 36.00 Mn |
| Sep 30, 2020 | 10.06 Mn |
API Access
Universe Pharmaceuticals Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=UPC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "UPC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=UPC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();